Neil Lineberry

1.1k citations
19 papers · 711 indexed · h-index 9
Topics
interferon and immune responses (7 papers)Cancer Immunotherapy and Biomarkers (7 papers)Ubiquitin and proteasome pathways (5 papers)

In The Last Decade

Neil Lineberry

18 papers receiving 708 citations

Peers

Neil Lineberry
Comparison fields: 5 of 100
  • Molecular Biology 340
  • Immunology 272
  • Oncology 141
  • Biomedical Engineering 70
  • Organic Chemistry 58
Replace Heather Myler with:
Heather Myler United States
Susana Gordo United States
Giuseppe A. Papalia United States
Cheng‐Pang Hsu United States
Marianne Scheel Fjording Denmark
Sudhir Shah United States
Luís Lima Portugal
P Au Canada
Kateřina Kuželová Czechia
Monique G.P. van der Wijst Netherlands
Neil Lineberry relative to Heather Myler United States Heather Myler's profile →
Citations per field
00.5×5.3×
Heather Myler · 1×
Citations per year

Countries citing papers authored by Neil Lineberry

Since Specialization
Citations

This map shows the geographic impact of Neil Lineberry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Lineberry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Lineberry more than expected).

Fields of papers citing papers by Neil Lineberry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Lineberry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Lineberry. The network helps show where Neil Lineberry may publish in the future.

Co-authorship network of co-authors of Neil Lineberry

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Lineberry. A scholar is included among the top collaborators of Neil Lineberry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Lineberry. Neil Lineberry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 3
5 12
6 14
7 1
8 2
9 2
10 5
11 70
12 2
13 37
14 241
15 62
16 49
17 142
18 62
19 4

About Neil Lineberry

Neil Lineberry is a scholar working on Immunology, Oncology and Biotechnology, having authored 19 papers that have together received 711 indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Immunology (272 citations), Oncology (141 citations) and Molecular Biology (340 citations). Neil Lineberry has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include C. Garrison Fathman, Leon Su, Galia Blum, Matthew Bogyo, Victoria E. Albrow, Margot G. Paulick, Laura E. Edgington‐Mitchell, Alicia B Berger, Luis Soares and Jack T. Lin. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026